Neuroscience

Targeting tau, the other protein behind Alzheimer's disease

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...

Medical research

Tackling the ethical considerations of dementia research

When Emily Largent worked as an ICU nurse at UCLA, she didn't shy away from the difficult cases. It wasn't necessarily the medical procedures themselves that were challenging; caring for patients after organ transplants or ...

Neuroscience

Down syndrome, like Alzheimer's, is a double-prion disorder

The brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer's disease and frequently demonstrate signs of the neurodegenerative disorder in their forties or fifties. ...

page 6 from 40